Clinical trial
Long-term Administration Study of SND 919 Tablets in Parkinson's Disease
NCT00274131 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274131 |
|---|---|
| Title | Long-term Administration Study of SND 919 Tablets in Parkinson's Disease |
| Official title | Long-term Administration Study of SND 919 Tablets in Parkinson's Disease |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Pramipexole 0.125 mg tablets, Pramipexole 0.5 mg tablets |
| Enrollment | 170 |
| Start date | Dec 1, 1998 |
| Completion | Feb 1, 2004 |
| First posted | Jan 10, 2006 |
| Last update posted | May 21, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: